Case Reports
doi: 10.3109/08880018809031253.
Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease
- PMID: 3152952
- DOI: 10.3109/08880018809031253
Item in Clipboard
Case Reports
Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease
Pediatr Hematol Oncol.
1988.
No abstract available
Similar articles
-
Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.J Pediatr Hematol Oncol. 2012 Apr;34(3):239-41. doi: 10.1097/MPH.0b013e3182352cf5. J Pediatr Hematol Oncol. 2012. PMID: 22246157
-
Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.J Am Osteopath Assoc. 1999 Mar;99(3):165-7. doi: 10.7556/jaoa.1999.99.3.165. J Am Osteopath Assoc. 1999. PMID: 10217912
-
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.J Pediatr Hematol Oncol. 2008 Jul;30(7):519-21. doi: 10.1097/MPH.0b013e31816624a4. J Pediatr Hematol Oncol. 2008. PMID: 18797198
-
Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I.Med Pediatr Oncol. 1989;17(6):520-3. doi: 10.1002/mpo.2950170534. Med Pediatr Oncol. 1989. PMID: 2685529 Review.
-
Vincristine neurotoxicity in the presence of hereditary neuropathy.Med Pediatr Oncol. 2003 Jan;40(1):39-43. doi: 10.1002/mpo.10105. Med Pediatr Oncol. 2003. PMID: 12426685 Review. No abstract available.
Cited by
-
A novel system to accelerate the progression of nerve degeneration in transgenic mouse models of neuropathies.Exp Neurol. 2012 Sep;237(1):153-9. doi: 10.1016/j.expneurol.2012.05.021. Epub 2012 Jun 9. Exp Neurol. 2012. PMID: 22688009 Free PMC article.
-
Acute neurotoxicity following vincristine due to Charcot-Marie-Tooth disease in a young child with medulloblastoma.Neurooncol Pract. 2019 May;6(3):179-184. doi: 10.1093/nop/npz002. Epub 2019 Mar 18. Neurooncol Pract. 2019. PMID: 31385990 Free PMC article.
-
Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1).Clin Case Rep. 2022 May 5;10(5):e05766. doi: 10.1002/ccr3.5766. eCollection 2022 May. Clin Case Rep. 2022. PMID: 35540715 Free PMC article.
-
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.Ann Neurol. 2014 Nov;76(5):727-37. doi: 10.1002/ana.24265. Epub 2014 Sep 17. Ann Neurol. 2014. PMID: 25164601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
